{
    "organizations": [],
    "uuid": "784e5ea85bba86479affe42f42c90f4e9727fce2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hofseth-biocare-q4-operating-reven/brief-hofseth-biocare-q4-operating-revenue-up-at-nok-26-4-million-idUSFWN1Q501O",
    "ord_in_thread": 0,
    "title": "BRIEF-Hofseth Biocare Q4 Operating Revenue Up At Nok ‍26.4​ Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - HOFSETH BIOCARE ASA:\n* Q4 OPERATING REVENUE NOK ‍26.4​ MILLION VERSUS NOK 3.1 MILLION YEAR AGO\n* Q4 EBITDA LOSS NOK ‍6.6​ MILLION VERSUS LOSS NOK 12.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-15T14:18:00.000+02:00",
    "crawled": "2018-02-16T17:15:28.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "hofseth",
        "biocare",
        "asa",
        "q4",
        "operating",
        "revenue",
        "nok",
        "million",
        "versus",
        "nok",
        "million",
        "year",
        "ago",
        "q4",
        "ebitda",
        "loss",
        "nok",
        "million",
        "versus",
        "loss",
        "nok",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}